GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386 · see citing works

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study

Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699 · see citing works

Smad-dependent and Smad-independent pathways in TGF-β family signalling

Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,370 · see citing works

Cause-Specific Excess Deaths Associated With Underweight, Overweight, and Obesity

Flegal, K. M., Graubard, B. I., Williamson, D. F., & Gail, M. H. (2007) · JAMA · doi:10.1001/jama.298.17.2028 · Cited by 1,542 · see citing works

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily

Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S. M., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,180 · see citing works

Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang‐Rodriguez, J., Moskaluk, C. A., Frierson, H. F., & Hampton, G. M. (2001) · PubMed · Cited by 851 · see citing works

Increased Number of Islet-Associated Macrophages in Type 2 Diabetes

Ehses, J. A., Perren, A. A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Guéripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783 · see citing works

The Transforming Growth Factor-β Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury

Kempf, T., Eden, M., Strelau, J., Naguib, M., Willenbockel, C., Tongers, J., Heineke, J., Kotlarz, D., Xu, J., Molkentin, J. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000202805.73038.48 · Cited by 651 · see citing works

Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans

Hingorani, A. D., Cross, J. M., Kharbanda, R. K., Mullen, M. J., Bhagat, K., Taylor, M., Donald, A. E., Palacios‐Callender, M., Griffin, G. E., Deanfield, J. E., et al. (2000) · Circulation · doi:10.1161/01.cir.102.9.994 · Cited by 605 · see citing works

Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension

Schillaci, G., Verdecchia, P., Porcellati, C., Cuccurullo, O., Cosco, C., & Perticone, F. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.580 · Cited by 528 · see citing works

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

Kempf, T., Zarbock, A., Widera, C., Butz, S., Stadtmann, A., Rossaint, J., Bolomini-Vittori, M., Korf-Klingebiel, M., Napp, L. C., Hansen, B., et al. (2011) · Nature Medicine · doi:10.1038/nm.2354 · Cited by 518 · see citing works

GDF15/MIC-1 Functions As a Protective and Antihypertrophic Factor Released From the Myocardium in Association With SMAD Protein Activation

Xu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 507 · see citing works

Large-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum

Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · see citing works

Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure

Kempf, T., von Haehling, S., Peter, T., Allhoff, T., Cicoira, M., Doehner, W., Ponikowski, P. P., Filippatos, G. S., Rozentryt, P., Drexler, H., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.091 · Cited by 492 · see citing works

Involvement of Extracellular Signal-Regulated Kinases 1/2 in Cardiac Hypertrophy and Cell Death

Bueno, O. F., & Molkentin, J. D. (2002) · Circulation Research · doi:10.1161/01.res.0000038488.38975.1a · Cited by 398 · see citing works

An immune origin of type 2 diabetes?

Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394 · see citing works

Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies

Cuspidi, C., Sala, C., Negri, F., et al. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.104 · Cited by 333 · see citing works

Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure

Anand, I. S., Kempf, T., Rector, T. S., Tapken, H., Allhoff, T., Jantzen, F., Kuskowski, M. A., Cohn, J. N., Drexler, H., & Wollert, K. C. (2010) · Circulation · doi:10.1161/circulationaha.109.928846 · Cited by 321 · see citing works

Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation

Wallentin, L. C., Hijazi, Z., Andersson, U., Alexander, J. H., Caterina, R. D., Hanna, M., Horowitz, J. D., Hylek, E. M., Lópes, R. D., Åsberg, S., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.011204 · Cited by 310 · see citing works

Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality

Wiklund, F. E., Bennet, A. M., Magnusson, P. K. E., Eriksson, U. K., Lindmark, F., Wu, L., Yaghoutyfam, N., Marquis, C. P., Stattin, P. E., Pedersen, N. L., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00629.x · Cited by 290 · see citing works

Diabetes and Cardiovascular Disease Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association

Grundy, S. M., Howard, B. V., Smith, S. R., Eckel, R. H., Redberg, R. F., & Bonow, R. O. (2002) · Circulation · doi:10.1161/01.cir.0000013952.86046.dd · Cited by 283 · see citing works

Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers

Koopmann, J., Buckhaults, P., Brown, D. A., ZAHURAK, M. L., Sato, N., Fukushima, N., Sokoll, L. J., Chan, D. W., Yeo, C. J., Hruban, R. H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0165 · Cited by 274 · see citing works

MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activation

Fairlie, W. D., Moore, A. G., Bauskin, A. R., Russell, P. K., Zhang, H.-P., & Breit, S. N. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.1.2 · Cited by 266 · see citing works

MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma.

Brown, D. A., Ward, R. L., Buckhaults, P., Liu, T., Romans, K. E., Hawkins, N. J., Bauskin, A. R., Kinzler, K. W., Vogelstein, B., & Breit, S. N. (2003) · PubMed · Cited by 265 · see citing works

PTGF-β , a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway

Tan, M., Wang, Y., Guan, K., & Sun, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.109 · Cited by 253 · see citing works

Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer

Bauskin, A. R., Brown, D. A., Kuffner, T., Johnen, H., Luo, X. W., Hunter, M., & Breit, S. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4067 · Cited by 251 · see citing works

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

Lind, L., Wallentin, L. C., Kempf, T., Tapken, H., Quint, A., Lindahl, B., Olofsson, S., Venge, P., Larsson, A. O., Hulthe, J., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp261 · Cited by 244 · see citing works

NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism

Chrysovergis, K., Wang, X., Kosak, J., Lee, S.-H., Kim, J. S., Foley, J. F., Travlos, G., Singh, S., Baek, S. J., & Eling, T. E. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.27 · Cited by 241 · see citing works

High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-κB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway

Ho, F. M., Lin, W., Chen, B. C., Chao, C. M., Yang, C., Lin, L., Lai, C. C., Liu, S., & Liau, C. S. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.05.009 · Cited by 237 · see citing works

The in vivo gene expression signature of oxidative stress

Han, E., Müller, F. L., Pérez, V., Qi, W., Liang, H., Liang, X., Fu, C., Doyle, E., Hickey, M., Cornell, J. E., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00239.2007 · Cited by 236 · see citing works

Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome

Wollert, K. C., Kempf, T., Lagerqvist, B., Lindahl, B., Olofsson, S., Allhoff, T., Peter, T., Siegbahn, A., Venge, P., Drexler, H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.697714 · Cited by 231 · see citing works

Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions

Schlittenhardt, D., Schober, A., Strelau, J., Bonaterra, G. A., Schmiedt, W., Unsicker, K., Metz, J., & Kinscherf, R. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0986-3 · Cited by 224 · see citing works

Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis

de Jager, S. C. A., Bermúdez, B., Bot, I., Koenen, R. R., Bot, M., Kavelaars, A., de Waard, V., Heijnen, C. J., Muriana, F. J. G., Weber, C., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100370 · Cited by 222 · see citing works

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction

Khan, S., Ng, K., Dhillon, O. S., Kelly, D., Quinn, P., Squire, I. B., Davies, J. E., & Ng, L. L. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn600 · Cited by 218 · see citing works

Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL

Jovinge, S. V., Ares, M. P. S., Kallin, B., et al. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1573 · Cited by 217 · see citing works

Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) Decreases Food Intake, Body Weight and Improves Glucose Tolerance in Mice on Normal & Obesogenic Diets

Macia, L., Tsai, V. W.-W., Nguyen, A. D., Johnen, H., Kuffner, T., Shi, Y.-C., Lin, S., Herzog, H., Brown, D. A., Breit, S. N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034868 · Cited by 211 · see citing works

Activin receptor–like kinase 1 is implicated in the maturation phase of angiogenesis

Lamouille, S., Mallet, C., Feige, J., & Bailly, S. (2002) · Blood · doi:10.1182/blood.v100.13.4495 · Cited by 211 · see citing works

Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury.

Zimmers, T. A., Jin, X., Hsiao, E. C., McGrath, S. A., Esquela, A. F., & Koniaris, L. G. (2005) · PubMed · Cited by 199 · see citing works

Identification of Macrophage Inhibitory Cytokine-1 in Adipose Tissue and Its Secretion as an Adipokine by Human Adipocytes

Ding, Q., Mráček, T., González‐Muniesa, P., Kos, K., Wilding, J. P. H., Trayhurn, P., & Chen, B. (2008) · Endocrinology · doi:10.1210/en.2008-0952 · Cited by 193 · see citing works

The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients

Vila, G., Riedl, M., Anderwald, C. H., Resl, M., Handisurya, A., Clodi, M., Prager, G., Ludvik, B. H., Krebs, M., & Luger, A. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.153726 · Cited by 185 · see citing works

Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet

Dostálová, I., Roubíček, T., Bártlová, M., Mráz, M., Lacinová, Z., Haluzíková, D., Kaválková, P., Matoulek, M., Kasalicky, M., & Haluzı́k, M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0417 · Cited by 183 · see citing works

Gene Expression Pattern in Biomechanically Stretched Cardiomyocytes

Frank, D., Kühn, C., Brors, B., Hanselmann, C., Lüdde, M., Katus, H. A., & Frey, N. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.098046 · Cited by 181 · see citing works

Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study

Rohatgi, A. K., Patel, P. C., Das, S. R., Ayers, C. R., Khera, A., Martinez‐Rumayor, A., Berry, J. D., McGuire, D. K., & de Lemos, J. A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.171926 · Cited by 179 · see citing works

Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial

Kempf, T., Guba-Quint, A., Torgerson, J., Magnone, M. C., Haefliger, C., Bobadilla, M., & Wollert, K. C. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0466 · Cited by 176 · see citing works

Growth/Differentiation Factor-15/Macrophage Inhibitory Cytokine-1 Is a Novel Trophic Factor for Midbrain Dopaminergic NeuronsIn Vivo

Strelau, J., Sullivan, A. M., Bottner, M. B., Lingor, P., Falkenstein, E., Suter‐Crazzolara, C., Galter, D., Jászai, J., KRIEGLSTEIN, K. G., & Unsicker, K. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08597.2000 · Cited by 175 · see citing works

Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells.

Liu, T., Bauskin, A. R., Zaunders, J. J., Brown, D. A., Pankhurst, S., Russell, P. J., Breit, S. N., & Panhurst, S. (2003) · PubMed · Cited by 174 · see citing works

Growth Differentiation Factor‐15 Deficiency Inhibits Atherosclerosis Progression by Regulating Interleukin‐6–Dependent Inflammatory Response to Vascular Injury

Bonaterra, G. A., Zügel, S., Thogersen, J., Walter, S., Haberkorn, U., Strelau, J., & Kinscherf, R. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002550 · Cited by 168 · see citing works

Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome

Bonaca, M. P., Morrow, D. A., D, E. B. M., Cannon, C. P., Jiang, S., Breher, S., Sabatine, M. S., Kempf, T., Wallentin, L. C., & Wollert, K. C. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213512 · Cited by 167 · see citing works

Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): Report of a case

Berkman, J., & Rifkin, H. (1973) · Metabolism · doi:10.1016/0026-0495(73)90243-6 · Cited by 167 · see citing works

GDF15, a Cardioprotective TGF-β Superfamily Protein

Ago, T., & Sadoshima, J. (2006) · Circulation Research · doi:10.1161/01.res.0000207919.83894.9d · Cited by 166 · see citing works

The Novel Biomarker Growth Differentiation Factor 15 in Heart Failure with Normal Ejection Fraction

Stahrenberg, R., Edelmann, F., Mende, M., Kockskämper, A., Düngen, H., Lüers, C., Binder, L., Herrmann‐Lingen, C., Gelbrich, G., Hasenfuss, G. P., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq151 · Cited by 161 · see citing works

Distinct Patterns of Transforming Growth Factor-β Isoform and Receptor Expression in Human Atherosclerotic Lesions

Bobik, A., Agrotis, A., Kanellakis, P., Dilley, R. J., Krushinsky, A. V., Smirnov, V. N., Tararak, E. M., Condron, M. M., & Kostolias, G. (1999) · Circulation · doi:10.1161/01.cir.99.22.2883 · Cited by 157 · see citing works

The Propeptide Mediates Formation of Stromal Stores of PROMIC-1: Role in Determining Prostate Cancer Outcome

Bauskin, A. R., Brown, D. A., Junankar, S. R., Rasiah, K., Eggleton, S. A., Hunter, M. I., Liu, T., Smith, D., Kuffner, T., Pankhurst, G. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3827 · Cited by 154 · see citing works

Circulating Growth Differentiation Factor-15 Correlates with Myocardial Fibrosis in Patients with Non-Ischaemic Dilated Cardiomyopathy and Decreases Rapidly After Left Ventricular Assist Device Support

Lok, S. I., Winkens, B., Goldschmeding, R., van Geffen, A. J. P., Nous, F. M. A., van Kuik, J., van der Weide, P., Klöpping, C., Kirkels, J. H., Lahpor, J. R., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs120 · Cited by 153 · see citing works

Potential biomarkers of ageing

Simm, A., Naß, N., Bartling, B., Hofmann, B., Silber, R., & Santos, A. N. (2008) · Biological Chemistry · doi:10.1515/bc.2008.034 · Cited by 146 · see citing works

Targeted Disruption of Smad4 in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure

Wang, J., Xu, N., Feng, X., Hou, N., Zhang, J., Cheng, X., Chen, Y., Zhang, Y., & Yang, X. Y. (2005) · Circulation Research · doi:10.1161/01.res.0000185833.42544.06 · Cited by 146 · see citing works

Secreted and cell surface genes expressed in benign and malignant colorectal tumors.

Buckhaults, P., Rago, C., Croix, B. S., Romans, K. E., Saha, S., Zhang, L., Vogelstein, B., & Kinzler, K. W. (2001) · PubMed · Cited by 145 · see citing works

Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD

Desai, A. S., Toto, R. D., Jarolı́m, P., Uno, H., Eckardt, K., Kewalramani, R., Levey, A. S., Lewis, E. F., McMurray, J. J. V., Parving, H., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.05.020 · Cited by 140 · see citing works

Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent

Kinscherf, R., Claus, R. A., Wagner, M., Gehrke, C., Kamencic, H., Hou, D., Nauen, O., Schmiedt, W., Kovács, G., Pill, J., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.6.461 · Cited by 134 · see citing works

GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men

Wallentin, L. C., Zethelius, B., Berglund, L., Eggers, K. M., Lind, L., Lindahl, B., Wollert, K. C., & Siegbahn, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078797 · Cited by 132 · see citing works

Growth Differentiation Factor 15 in Heart Failure: An Update

Wollert, K. C., & Kempf, T. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0113-9 · Cited by 128 · see citing works

Growth differentiation factor 15 acts anti‐apoptotic and pro‐hypertrophic in adult cardiomyocytes

Heger, J., Schiegnitz, E., von Waldthausen, D., Anwar, M. M., Piper, H. M., & Euler, G. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22102 · Cited by 125 · see citing works

Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3

Secchiero, P., Corallini, F., Gonelli, A., Dell’Eva, R., Vitale, M., Capitani, S., Albini, A., & Zauli, G. (2006) · Circulation Research · doi:10.1161/01.res.0000253975.76198.ff · Cited by 125 · see citing works

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy

Lajer, M., Jorsal, A., Tarnow, L., Parving, H., & Rossing, P. R. (2010) · Diabetes Care · doi:10.2337/dc09-2174 · Cited by 124 · see citing works

Caspase-3 and Tissue Factor Expression in Lipid-Rich Plaque Macrophages

Hutter, R., Valdiviezo, C., Sauter, B. V., Savontaus, M., Chereshnev, I., Carrick, F. E., Bauriedel, G., Lüderitz, B., Fallon, J. T., Fuster, V., et al. (2004) · Circulation · doi:10.1161/01.cir.0000125526.91945.ae · Cited by 119 · see citing works

Cardiokines: recent progress in elucidating the cardiac secretome

Shimano, M., Ouchi, N., & Walsh, K. (2012) · Circulation · doi:10.1161/circulationaha.112.150656 · Cited by 116 · see citing works

Human cDNA Encoding a Novel TGF- Superfamily Protein Highly Expressed in Placenta

Yokoyama-Kobayashi, M., Saeki, M., Sekine, S., & Kato, S. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021798 · Cited by 116 · see citing works

Biomarkers of Cardiovascular Stress and Incident Chronic Kidney Disease

Ho, J. E., Hwang, S., Wollert, K. C., Larson, M. G., Cheng, S. C., Kempf, T., Vasan, R. S., Januzzi, J. L., Wang, T. J., & Fox, C. S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.205716 · Cited by 113 · see citing works

Multiple marker approach to risk stratification in patients with stable coronary artery disease

Schnabel, R. B., Schulz, A., Messow, C., Lubos, E., Wild, P. S., Zeller, T., Sinning, C., Rupprecht, H. J., Bickel, C., Peetz, D., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq322 · Cited by 112 · see citing works

Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline

Allender, S. E., Scarborough, P., O’Flaherty, M., & Capewell, S. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-148 · Cited by 111 · see citing works

Adaptive Induction of Growth Differentiation Factor 15 Attenuates Endothelial Cell Apoptosis in Response to High Glucose Stimulus

Li, J., Yang, L., Qin, W., Zhang, G., Yuan, J., & Wang, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065549 · Cited by 110 · see citing works

Apoptosis induced by oxidized low density lipoprotein in human monocyte‐derived macrophages involves CD36 and activation of caspase‐3

Wintergerst, E. S., Jelk, J., Rahner, C., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01682.x · Cited by 109 · see citing works

Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis

Brown, D. A., Stephan, C., Ward, R. L., Law, M. G., Hunter, M., Bauskin, A. R., Amin, J., Jung, K., Diamandis, E. P., Hampton, G. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1331 · Cited by 109 · see citing works

Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits

Kinscherf, R., Deigner, H., Usinger, C., Pill, J., Wagner, M., Kamencic, H., Hou, D., Chen, M., Schmiedt, W., Schrader, M., et al. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.14.9409551 · Cited by 105 · see citing works

Signaling of Reactive Oxygen and Nitrogen Species in Diabetes Mellitus

Afanasʹev, I. B. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.6.14415 · Cited by 100 · see citing works

Topographical Association Between the Cyclin-Dependent Kinases Inhibitor P21, p53 Accumulation, and Cellular Proliferation in Human Atherosclerotic Tissue

Ihling, C. H., Menzel, G., Wellens, E., Mönting, J. S., Schaefer, H. E., & Zeiher, A. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2218 · Cited by 99 · see citing works

Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary Syndrome

Eggers, K. M., Kempf, T., Lagerqvist, B., Lindahl, B., Olofsson, S., Jantzen, F., Peter, T., Allhoff, T., Siegbahn, A. G., Venge, P., et al. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.877456 · Cited by 96 · see citing works

Myocardial Infarction Enhances Progressive Renal Damage in an Experimental Model for Cardio-Renal Interaction

van Dokkum, R. P. E., Eijkelkamp, W. B. A., Kluppel, A. C. A., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145895.62896.98 · Cited by 91 · see citing works

Colocalization of CPP-32 With Apoptotic Cells in Human Atherosclerotic Plaques

Mallat, Z., Ohan, J., Lesèche, G., & Tedgui, A. (1997) · Circulation · doi:10.1161/01.cir.96.2.424 · Cited by 86 · see citing works

GDF15 Triggers Homeostatic Proliferation of Acid-Secreting Collecting Duct Cells

Huyen, J. D. V., Cheval, L., Bloch-Faure, M., Bélair, M. F., Heudes, D., Bruneval, P., & Doucet, A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007070781 · Cited by 84 · see citing works

Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery

Bermúdez, B., López, S., Pacheco, Y. M., Villar, J. R., Muriana, F. J. G., Hoheisel, J. D., Bauer, A. S., & Abia, R. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn082 · Cited by 84 · see citing works

Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes

Mazagova, M., Buikema, H., van Buiten, A., Duin, M., Goris, M., Sandovici, M., Henning, R. H., & Deelman, L. E. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00387.2013 · Cited by 80 · see citing works

Circulating and Placental Growth-Differentiation Factor 15 in Preeclampsia and in Pregnancy Complicated by Diabetes Mellitus

Sugulle, M., Dechend, R., Herse, F., Weedon-Fekjær, M. S., Johnsen, G. M., Brosnihan, K. B., Anton, L., Luft, F. C., Wollert, K. C., Kempf, T., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.130583 · Cited by 78 · see citing works

The Transforming Growth Factor-β Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)Retinamide

Ferrari, N., Pfeffer, U., Dell’Eva, R., Ambrosini, C., Noonan, D. M., & Albini, A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2210 · Cited by 75 · see citing works

Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass

Kahli, A., Guénancia, C., Zeller, M., Grosjean, S. A., Stamboul, K., Rochette, L., Girard, C., & Vergely, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105759 · Cited by 74 · see citing works

Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study

Carstensen, M., Herder, C., Brunner, E. J., Straßburger, K., Tabák, Á. G., Roden, M., & Witte, D. R. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1066 · Cited by 72 · see citing works

Growth Differentiation Factor (GDF)-15 Blocks Norepinephrine-induced Myocardial Hypertrophy via a Novel Pathway Involving Inhibition of Epidermal Growth Factor Receptor Transactivation

Xu, X., Nie, Y., Wang, F.-F., Bai, Y., Lv, Z.-Z., Zhang, Y., Li, Z., & Gao, W. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.516278 · Cited by 66 · see citing works

Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study)

Schopfer, D. W., Ku, I. A., Regan, M. C., & Whooley, M. A. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.09.013 · Cited by 64 · see citing works

Altered plasma levels of cytokines in patients with ischemic heart disease

Tashiro, H., Shimokawa, H., Yamamoto, K., et al. (1997) · Coronary Artery Disease · doi:10.1097/00019501-199703000-00004 · Cited by 57 · see citing works

Growth Differentiation Factor-15: a New Biomarker in Cardiovascular Disease

Kempf, T., & Wollert, K. C. (2009) · Herz · doi:10.1007/s00059-009-3317-3 · Cited by 56 · see citing works

Usefulness of Growth Differentiation Factor-15 Levels to Predict Diabetic Cardiomyopathy in Asymptomatic Patients With Type 2 Diabetes Mellitus

Domínguez‐Rodríguez, A., Abreu-González, P., & y, P. A. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.06.020 · Cited by 56 · see citing works

Cardiac myocyte gene expression profiling during H2O2-induced apoptosis

Clerk, A., Kemp, T. J., Zoumpoulidou, G., & Sugden, P. H. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00168.2006 · Cited by 56 · see citing works

Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development

Huh, S. J., Chung, C.-Y., Sharma, A. K., & Robertson, G. P. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090963 · Cited by 53 · see citing works

The Story of Growth Differentiation Factor 15: Another Piece of the Puzzle

Lindahl, B. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.212811 · Cited by 52 · see citing works

Interventional studies concerning the role of antioxidant vitamins in cardiovascular diseases: a review.

Czernichow, S., & Herçberg, S. (2001) · PubMed · Cited by 51 · see citing works

TGF-β in the Cardiovascular System

Topper, J. N. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00061-x · Cited by 48 · see citing works

Characterization of apoptotic macrophages in atheromatous tissue of humans and heritable hyperlipidemic rabbits

Kinscherf, R. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00037-4 · Cited by 47 · see citing works

Growth Differentiation Factor-15 in the Early Diagnosis and Risk Stratification of Patients with Acute Chest Pain

Schaub, N., Reichlin, T., Twerenbold, R., Reiter, M., Steuer, S., Bassetti, S., Stelzig, C., Wolf, C., Winkler, K., Haaf, P., et al. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.173310 · Cited by 47 · see citing works

Modified low density lipoprotein delivers substrate for ceramide formation and stimulates the sphingomyelin‐ceramide pathway in human macrophages

Kinscherf, R., Claus, R. A., Deigner, H. P., et al. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00157-9 · Cited by 45 · see citing works

p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms

Kelly, J. A., Lucia, M. S., & Lambert, J. R. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.013 · Cited by 40 · see citing works

Lipotoxicity and glucotoxicity in type 2 diabetes

Sivitz, W. I. (2001) · Postgraduate Medicine · doi:10.3810/pgm.2001.04.908 · Cited by 38 · see citing works

Growth-Differentiation Factor-15 and Major Cardiac Events

Lin, J.-F., Wu, S., Hsu, S., Yeh, K.-H., Chou, H., Cheng, S.-T., Wu, T.-Y., Hsu, W.-T., Yang, C., & Ko, Y. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318291cd4e · Cited by 38 · see citing works

Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53

Chen, B., Lu, D., Fu, Y., Zhang, J., Huang, X., Cao, S., Xu, D., Bin, J., Kitakaze, M., Huang, Q., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12736 · Cited by 36 · see citing works

Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis

Yilmaz, H., Çelik, H. T., Gurel, O. M., Bilgiç, M. A., Namuslu, M., Bozkurt, H., Ayyildiz, A., İnan, O., Bavbek, N., & Akçay, A. (2014) · Herz · doi:10.1007/s00059-014-4139-5 · Cited by 35 · see citing works

The renal transcriptome ofdb/dbmice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study

Simonson, M. S., Tiktin, M., Debanne, S. M., Rahman, M., Berger, B., Hricik, D. E., & Ismail‐Beigi, F. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2011 · Cited by 34 · see citing works

Fator de diferenciação de crescimento 15: um novo biomarcador em pacientes com disfunção diastólica?

Dinh, W., Füth, R., Lankisch, M., Heß, G., Zdunek, D., Scheffold, T., Kramer, F., Klein, R. M., Barroso, M. C., & Nickl, W. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011005000058 · Cited by 34 · see citing works

The Association of Growth Differentiation Factor-15 with Left Ventricular Hypertrophy in Hypertensive Patients

Xue, H., Fu, Z., Chen, Y., Xing, Y., Liu, J., Zhu, H., & Zhou, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046534 · Cited by 32 · see citing works

Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts

Hanatani, S., Izumiya, Y., Takashio, S., Kojima, S., Yamamuro, M., Araki, S., Rokutanda, T., Tsujita, K., Yamamoto, E., Tanaka, T., et al. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0337-y · Cited by 24 · see citing works

Polarised secretion of cytokines in primary human microvascular endothelial cells is not dependent on N‐linked glycosylation

Jurczyluk, J., Brown, D. A., & Stanley, K. K. (2003) · Cell Biology International · doi:10.1016/j.cellbi.2003.09.002 · Cited by 17 · see citing works

[Value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy].

Li, H., Gao, F., Xue, Y., et al. (2014) · PubMed · Cited by 14 · see citing works

Multimarker Approach for the Prediction of Cardiovascular Events in Patients With Mild to Moderate Coronary Artery Lesions

Zhang, M., Lü, S.-Z., Wu, X., Chen, Y., Song, X., Jin, Z., Li, H., Zhou, Y., Chen, F., & Huo, Y. (2012) · International Heart Journal · doi:10.1536/ihj.53.85 · Cited by 9 · see citing works

Growth Differentiation Factor 15, Ischemia Modified Albumin and Pregnancy-Associated Plasma Protein A in Patients with Coronary Artery Disease

Fan, L., Jin, Z., Zong, M., et al. (2014) · Clinical Laboratory · doi:10.7754/clin.lab.2013.130448 · Cited by 8 · see citing works

[Prevalence and relevant factors on echocardiographic left ventricular hypertrophy among community-based hypertensive patients in Shanghai].

Zhan, S., Liu, M., Yao, W., et al. (2002) · PubMed · Cited by 8 · see citing works

S73 Circulating Regulators of Acute Muscle Wasting in the Critically Ill: GDF-15 a Potential Novel Driver of Acute Muscle Wasting

Bloch, S., Lee, J., Wort, S. J., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202678.079 · Cited by 3 · see citing works

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL

Emmerson, P. J., Wang, F., Du, Y., Liu, Q., Pickard, R. T., Gonciarz, M. D., Coskun, T., Hamang, M. J., Sindelar, D. K., Ballman, K. K., et al. (2017) · Nature Medicine · doi:10.1038/nm.4393 · Cited by 675 · see citing works

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint

Wischhusen, J., Melero, I., & Fridman, W. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00951 · Cited by 506 · see citing works

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan

Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278 · see citing works

Human Aging and Longevity Are Characterized by High Levels of Mitokines

Conte, M., Ostan, R., Fabbri, C., Santoro, A., Guidarelli, G., Vitale, G., Mari, D., Sevini, F., Capri, M., Sandri, M., et al. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly153 · Cited by 219 · see citing works

Growth differentiation factor 15 (GDF15): a survival protein with therapeutic potential in metabolic diseases

Baek, S. J., & Eling, T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.008 · Cited by 194 · see citing works

Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond

Mullican, S. E., & Rangwala, S. M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.05.002 · Cited by 127 · see citing works

Overview of growth differentiation factor 15 in metabolic syndrome

Asrih, M., Wei, S., Nguyen, T. T., Yi, H., Ryu, D., & Gariani, K. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17725 · Cited by 70 · see citing works

The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update

Arkoumani, M., Papadopoulou-Marketou, N., Nicolaides, N. C., Kanaka-Gantenbein, C., Tentolouris, N., & Papassotiriou, I. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1678565 · Cited by 64 · see citing works

GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin

Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Peng, X., Chen, Y., & Routy, J.-P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.581839 · Cited by 39 · see citing works

Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans

Lemmelä, S., Wigmore, E. M., Benner, C., Havulinna, A. S., Ong, R. M., Kempf, T., Wollert, K. C., Blankenberg, S., Zeller, T., Peters, J. E., et al. (2022) · eLife · doi:10.7554/elife.76272 · Cited by 28 · see citing works

Effect of metformin and celecoxib on cytotoxicity and release of GDF-15 from human mesenchymal stem cells in high glucose condition

Zafarvahedian, E., Roohi, A., Sepand, M. R., Ostad, S. N., & Ghahremani, M. H. (2017) · Cell Biochemistry and Function · doi:10.1002/cbf.3289 · Cited by 8 · see citing works

Effects of resveratrol on endothelial nitric oxide synthase (eNOS) phosphorylation and interaction with regulatory proteins

Araj, C. A., Slack, K. N., & Harris, M. B. (2008) · The FASEB Journal · doi:10.1096/fasebj.22.1_supplement.1154.7 · Cited by 1 · see citing works

Differential response to myocardial reperfusion injury in eNOS-deficient mice

Sharp, B. R., Jones, S. P., Rimmer, D. M., & Lefer, D. J. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00855.2001 · Cited by 95 · see citing works

Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells

Yoon, H. J., Cho, S. W., Ahn, B. W., & Yang, S. Y. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.12.010 · Cited by 63 · see citing works

Interaction between regulatory proteins related to the activation of eNOS and CYP4A/20-HETE

Bi, H.-R. (2007)

Homocysteine inhibits activity of eNOS in endothelial cells from human umbilical vein

He, F. (2011) · Basic & Clinical Medicine